About
About the PDA Letter
PDA Letter is PDA's online membership magazine covering the science, technology, and regulation behind the manufacturing of sterile injectable pharmaceutical and biopharmaceutical products. It also is the primary source of communication about PDA events, chapters, membership, training, and other important Association business. Legacy print editions can be found in in the “pdf archive.” Articles are uploaded to the website weekly on Tuesdays, Wednesdays, and/or Thursdays. Two feature-length articles (1500-2000 words) are published monthly. Content includes On-The-Issue videos and PDA Spotlight audio podcasts.
The PDA Letter will publish feature-length articles on the following topics in 2024. (This list is subject to change.)
Month | Subject | Month | Subject |
---|---|---|---|
January 2025 | Contamination Control Strategy | July 2025 | PDA/FDA Conference |
February 2025 | PDA Week 2025 | August 2025 | Gene Sequencing |
March 2025 | Pharmaceutical in the Digital Age | September 2024 | Sterile Processing |
April 2025 | Ethical Issues in Pharmaceutical Research | October 2025 | Visual Inspection |
May 2025 | Challenges and Innovations in Vaccine Development | November 2025 | Clinical Trials and Research |
June 2025 | AI and the Regulatory Landscape | December 2025 | Future of Pharma |
Readers can sort PDA Letter articles by the following PDA-critical Article Categories:
- People
- Aseptic Processing & Sterilization
- Biopharmaceuticals & Biotechnology
- Manufacturing Science
- Quality & Regulatory
- Supply Chain
Interested Authors should be active PDA Members and should carefully review the Submit page before submitting to PDA Letter. An all-volunteer Editorial Committee assists PDA in choosing articles for publication. Every year, PDA needs new volunteers to help fill seats on the committee, so if you are interested send an email to PLEC@pda.org.
PDA Letter Editorial Committee (PLEC)
-
Claire Briglia
Vedere Solutions
-
-
Subrata Chakraborty
GxPfont Consulting Group
-
-
Dave Exline
PDA Science Advisory Board
-
Michele Ford
Grifols Therapeutics
-
-
Tamer Helmy, PhD
Molecular Templates
-
David Hubmayr
CSL Behring
-
-
Brandon Perrone
-
PDA Letter Staff
-
Walter Morris
Sr. Director, Publishing & Press Relations
-
Katja Yount
Publication Design Specialist
-
Justin Johnson
Managing Editor